News | Breast Imaging | April 04, 2017

Mercy Medical Center in Long Island Installs LumaGEM Molecular Breast Imaging System

New secondary screening method enables early cancer detection in women with dense breast tissue

Gamma Medica, LumaGEM molecular breast imaging system, MBI, Mercy Medical Center, Long Island, first New York install

April 4, 2017 — Gamma Medica announced in late March that Mercy Medical Center, a member of Catholic Health Services of Long Island, has purchased and installed New York’s first clinical LumaGEM Molecular Breast Imaging (MBI) system.

MBI is a secondary screening and diagnostic tool that is particularly useful for women who have dense breast tissue and women with a high risk of being diagnosed with cancer. It is a supplementary screening method to mammography, significantly increasing early detection in women who are at a higher risk due to dense breast tissue.

Approximately 50 percent of U.S. women are reported to have dense breast tissue. However, many women do not realize they have dense breasts or what it means for their increased risk of breast cancer. Because dense breast tissue and cancer both appear white on mammograms, cancer detection through mammography alone is difficult and may lead to false negatives or delayed diagnoses. Over 40,000 U.S. women die from breast cancer annually, making early detection imperative.

“The acquisition of the Molecular Breast Imaging system will better enable the detection of cancer to save lives,” said Mercy’s Executive Vice President and Chief Administrative Officer Ron Steimel. “This is just the latest milestone in Mercy’s longstanding dedication to the fight against cancer.”

While mammograms may fail to detect breast tumors due to tissue density, MBI highlights metabolic activity in these tumors despite breast density, leading to an earlier diagnosis. A retrospective clinical study published in the August 2016 issue of the American Journal of Roentgenology confirmed MBI’s high incremental cancer detection rate: MBI was able to detect 7.7 cancers per 1,000 women screened that were not found using mammography. Approximately 85 percent of these cancers were node negative, meaning they were detected at an earlier stage and presented a better prognosis.

“Mercy Medical Center is thrilled to add Gamma Medica’s LumaGEM to our suite of leading breast imaging technology,” said Conellia Ha, M.D., director of radiology at Mercy. “As a supplement to 3-D mammography, MBI will help us detect cancers in dense tissue that may have been missed by mammography alone. We feel confident that LumaGEM will support our mission to provide the best diagnostic care for our patients—the data behind MBI speaks for itself.”

For more information: www.gammamedica.com

Related Content

Sectra Signs Enterprise Imaging Contract With Vanderbilt Health
News | Enterprise Imaging | August 21, 2019
Sectra will install its enterprise imaging picture archiving and communication system (PACS) and vendor neutral archive...
Some Pregnant Women Are Exposed to Gadolinium in Early Pregnancy
News | Women's Health | August 20, 2019
A small but concerning number of women are exposed to a commonly used magnetic resonance imaging (MRI) contrast agent...
Lunit Receives Korea MFDS Approval for Lunit Insight MMG
News | Artificial Intelligence | August 19, 2019
Lunit has announced Korea Ministry of Food and Drug Safety (MFDS) approval of its artificial intelligence (AI) solution...
United Imaging Announces First U.S. Clinical Installation of uExplorer Total-body PET/CT
News | PET-CT | August 15, 2019
United Imaging announced that its uExplorer total-body positron emission tomography/computed tomography (PET/CT) system...
Imago Systems Announces Collaboration With Mayo Clinic for Breast Imaging

Image courtesy of Imago Systems

News | Mammography | August 14, 2019
Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year...
Artificial Intelligence Could Yield More Accurate Breast Cancer Diagnoses
News | Artificial Intelligence | August 13, 2019
University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that...
Lake Medical Imaging Selects Infinitt for Multi-site RIS/PACS
News | PACS | August 09, 2019
Infinitt North America will be implementing Infinitt RIS (radiology information system)/PACS (picture archiving and...
Volpara to Distribute Screenpoint Medical's Transpara AI Solution
News | Breast Imaging | August 02, 2019
Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint's Transpara...
ASRT Supports Radiopharmaceutical Reimbursement Bill
News | Radiopharmaceuticals and Tracers | August 02, 2019
The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) 3772, a measure...
International Multidisciplinary Group Publishes Recommendations for Personalized HCC Treatment With Y90 TheraSphere
News | Interventional Radiology | July 31, 2019
New consensus recommendations for personalized treatment for hepatocellular carcinoma (HCC) with BTG’s TheraSphere have...